What The Walk Foundation does

The Walk Foundation is a 501(c)(3) nonprofit organization founded in 2014 and headquartered in Indian Rocks Beach, Florida, that supports individuals with neuromuscular disorders through electrostimulation therapies, equipment funding, and mobility programs. The foundation was established by Dr. George Maltezos, an electrical engineer and former director of the California Institute of Technology Global Health Initiative, originally partnering with Sigmedics to provide donated Parastep systems. The organization was revived in 2024 under Executive Director Tony Doblin, a bilateral below-the-knee amputee who achieved mobility milestones using the Neuro20 PRO System, and the mission was realigned around Neuro20 Technologies' whole-body electrophysiological neuromodulation platform.

The foundation's core offering is the Neuro20 PRO System, an FDA-cleared medical-grade device combining a Smart Suit with 20 contoured electrodes that stimulate over 42 muscles, a wireless Control Box with rechargeable battery, and proprietary software running 4 main programs plus 9 additional modes for patterned electrical stimulation (NMES/FES/PEMS). It is distributed through a Patient Access Initiative launched in partnership with Neuro20 Technologies in June 2026, placing systems directly into patients' homes and bypassing insurance delays; seven patients have received systems to date. Target populations include spinal cord injury patients, amputees, stroke and neurological injury patients, and individuals with MS, Parkinson's, Long COVID, and diabetic neuropathy.

The foundation operates a donations-only revenue model (no disclosed pricing, no commercial sales) and reaches supporters through its website (togetherwewalk.org), newsletter, video testimonials, fundraising events such as "A Night of Laughs," and the planned 2027 "Summit Within" Mount Kilimanjaro expedition featuring ten amputee climbers. Leadership comprises Executive Director Tony Doblin, Director of Science Dr. George Maltezos, Director of Rehabilitation Monica Joshi (38+ years of international rehabilitation experience), and board members Suzy Lee and attorney Donald Blydenburgh. The foundation is small (1-10 employees), operates domestically in the United States, and has no disclosed funding rounds, subsidiaries, or M&A activity.

Name

The Walk Foundation

Legal name

The Walk Foundation

Website

https://togetherwewalk.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

The Walk Foundation is a 501(c)(3) nonprofit that provides neuromuscular patients with access to FDA-cleared Neuro20 electrostimulation systems, equipment funding, and mobility support, distributing devices directly into patients' homes via a Neuro20 Technologies partnership.

Ownership category

akta.pro rank

Product category

Neuromuscular Rehabilitation Services

NAICS

Services for the Elderly and Persons with Disabilities (624120), Voluntary Health Organizations (813212)

SIC

Services-Home Health Care Services (8082), Electromedical & Electrotherapeutic Apparatus (3845), Services-Health Services (8000)

akta.pro primary industry

Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s) (HSABADAE)

akta.pro secondary industry

Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Neuromuscular rehabilitation
• Electrostimulation therapy
• Neurostimulation devices
• Patient access programs
• Mobility assistance

Headquarters

HQ city

Indian Rocks Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: The Walk Foundation is a 501(c)(3) nonprofit organization that relies on donations to fund its mission of providing Neuro20 technology to individuals with neuromuscular disorders.

Distribution channels1 record

Marketing channels7 records

Core offering

The Walk Foundation is a 501(c)(3) nonprofit organization that provides individuals with neuromuscular disorders with access to FDA-cleared electrostimulation technology (Neuro20 PRO System) and mobility support. Through its Patient Access Initiative partnered with Neuro20 Technologies, the foundation places the Neuro20 PRO System directly into patients' homes, bypassing insurance delays, while also advocating for research and supporting recovery journeys for conditions including spinal cord injuries, amputations, stroke, MS, Parkinson's, Long COVID, and diabetic neuropathy.

Product overview

The Walk Foundation offers a unified product ecosystem centered on the Neuro20 PRO System, an FDA-cleared whole-body neurorehabilitation device. The system comprises four integrated components: the Neuro20 Smart Suit (wearable with 20 electrodes), the Neuro20 PRO Control Box (wireless muscle stimulator), the Neuro20 PRO Software (with 13 programs for electrical stimulation), and the Operating Tablet. The foundation provides this technology to individuals with neurological conditions including strokes, spinal cord injuries, amputations, Multiple Sclerosis, Parkinson's, Long COVID, and diabetic neuropathy.

Differentiator

Problem solved

Functional benefit

Products and services

• Neuro20 PRO System FDA-cleared medical-grade recovery system combining an advanced software platform with a whole-body Electrophysiological Neuromodulation Smart Suit to recreate specific functional movement patterns, strength, endurance, and recovery. Designed to treat musculoskeletal injury and neuromuscular disease, provided to patients through The Walk Foundation's Patient Access Initiative.
• Neuro20 Smart Suit Whole-body wearable that uses Electrophysiological Neuromodulation to recruit Type I and II muscle fibers, utilizing 20 large contoured electrodes to engage motor neurons and stimulate over 42 muscles to promote recovery. Component of the Neuro20 PRO System made available through The Walk Foundation.
• Neuro20 PRO Software Software platform containing various programs for NMES/FES/PEMS (patterned electrical stimulation) that replicates movements in sequenced timing patterns. Includes 4 main programs with 9 additional modes, capable of isolating individual muscles or recruiting full body motor chains. Component of the Neuro20 PRO System made available through The Walk Foundation.
• Neuro20 PRO Control Box Powered muscle stimulator that attaches to the Smart Suit, generating electrical impulses and controlled wirelessly through the Neuro20 PRO Software on the Operating Tablet. Powered by a rechargeable, replaceable battery. Component of the Neuro20 PRO System made available through The Walk Foundation.
• Patient Access Initiative A flagship program operated by The Walk Foundation in partnership with Neuro20 Technologies that places FDA-cleared Neuro20 PRO Systems directly into the homes of patients with neurological conditions (stroke, spinal cord injury, amputation, MS, Parkinson's, Long COVID, diabetic neuropathy), bypassing insurance delays and making advanced neuromuscular rehabilitation technology accessible to individual patients.

Quantifiable outcome

• Seven patients have received Neuro20 PRO Systems through the Patient Access Initiative
• +2 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Neuro20 Technologies Corp.flagshipStrategic or Co-development Partner · 30 June 2026Neuro20 Technologies partnered with The Walk Foundation to launch a Patient Access Initiative placing FDA-cleared Neuro20 PRO Systems into homes of patients with neurological conditions. The initiative bypasses insurance delays, with seven patients already receiving systems. Neuro20 maintains an IRB-approved clinical trial pipeline spanning elite institutions including Johns Hopkins, UCSF, and Brooks Rehabilitation. The Walk Foundation, revived by bilateral amputee Tony Doblin who achieved mobility milestones using the system, supports this initiative as part of its mission.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• ALS Association: National 501(c)(3) serving patients with ALS and other neuromuscular diseases through research funding and care services. Comparable as a voluntary health organization addressing neuromuscular mobility challenges.
• Christopher & Dana Reeve Foundation: National nonprofit dedicated to advancing spinal cord injury research, treatment, and quality of life. Directly comparable to The Walk Foundation in mission (serving spinal cord injury patients with mobility-restoration technologies) and revenue model (501(c)(3) donor-funded).
• Bioness Inc. Commercial manufacturer of FDA-cleared NMES/FES devices for foot drop, hand paralysis, and functional stimulation. Closest commercial analog to the Neuro20 PRO System in technology category and patient population (stroke, MS, spinal cord injury).
• Michael J. Fox Foundation for Parkinson's Research: Large 501(c)(3) funding Parkinson's research and patient support. Direct peer given The Walk Foundation's explicit focus on Parkinson's mobility rehabilitation through Neuro20 electrostimulation.
• Neuro20 Technologies Corp. The Walk Foundation's flagship technology partner; manufactures the FDA-cleared Neuro20 PRO whole-body electrophysiological neuromodulation suit that the foundation distributes to patients. Directly comparable because the foundation's entire service offering is built around Neuro20's platform.
• Restorative Therapies: Manufacturer of FES cycling and therapy systems used in clinical and home-based neuromuscular rehabilitation for spinal cord injury, stroke, and MS. Direct peer in the FES/electrostimulation rehab category.
• Paralyzed Veterans of America: 501(c)(3) advocacy and services organization for veterans with spinal cord injuries and disabilities. Comparable in mission focus on spinal cord injury mobility and in nonprofit donor-funded service delivery.
• National Multiple Sclerosis Society: Major 501(c)(3) focused on MS research, treatment access, and quality of life. Closely aligned with The Walk Foundation's patient segments (MS patients using Neuromodulation) and nonprofit fundraising model.

Emerging players

• Ekso Bionics: Developer of robotic exoskeletons for stroke, spinal cord injury, and MS rehabilitation. Comparable in serving the same neuromuscular patient segments with a different (robotic) modality, representing both peer and adjacent technology.
• ReWalk Robotics: Public company developing exoskeleton systems for spinal cord injury and stroke mobility. Comparable as a mobility-restoration technology player addressing overlapping patient populations, though with a robotic rather than electrostimulation approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Walk Foundation